FCAG
BNTX icon

First Capital Advisors Group’s BioNTech BNTX Stock Holding History

First Capital Advisors Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$3.24K Buy
+30
New +$3.37K ﹤0.01% 731

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Capital Advisors Group's BNTX Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in BioNTech (BNTX) in Q2 2023: 30 shares worth $3.24K. The stake represents ﹤0.01% of the portfolio and ranks #731 among its holdings.

253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • First Capital Advisors Group held 30 shares of BioNTech worth $3.24K as of Q2 2023.
  • BioNTech was a new First Capital Advisors Group position in Q2 2023.
  • BioNTech made up ﹤0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #731 holding.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.